These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9260262)

  • 41. Intranasal administration of demopressin (DDAVP) for type 1 and type 2A von Willebrand disease.
    Mohri H; Hashimoto Y; Yamazaki E; Kanamori H; Okubo T
    Hematopathol Mol Hematol; 1998; 11(2):109-15. PubMed ID: 9608359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Acute water intoxication caused by intranasal desmopressin--Minirine].
    Wagner A; Skriver EB; Pedersen H
    Ugeskr Laeger; 1997 May; 159(19):2889. PubMed ID: 9190722
    [No Abstract]   [Full Text] [Related]  

  • 43. Hyponatraemia following desmopressin.
    Robson WL; Leung AK
    BMJ; 1993 Jul; 307(6895):64-5. PubMed ID: 8343697
    [No Abstract]   [Full Text] [Related]  

  • 44. Life threatening biphasic adverse reactions to desmopressin: case report and review of the literature.
    Wang L; Chen R; Tian F; Wang W; Wang L; Yu B; Huang X; Zhang Y; Su S; Ma G; Wang K
    Int J Clin Pharmacol Ther; 2016 Aug; 54(8):640-4. PubMed ID: 27142268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biologic response to subcutaneous and intranasal therapy with desmopressin in a large Amish kindred with Type 2M von Willebrand disease.
    Sharthkumar A; Greist A; Di Paola J; Winay J; Roberson C; Heiman M; Herbert S; Parameswaran R; Shapiro A
    Haemophilia; 2008 May; 14(3):539-48. PubMed ID: 18312368
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Water intoxication in infants caused by the urine concentration test with vasopressin analogue (DDAVP).
    Koskimies O; Pylkkänen J; Vilska J
    Acta Paediatr Scand; 1984 Jan; 73(1):131-2. PubMed ID: 6702442
    [No Abstract]   [Full Text] [Related]  

  • 47. Recurrent hyponatremia under desmopressin overdosing: is abuse a possible explication?
    Hillemacher T; Schanze A; Kraus T; Kornhuber J; Bleich S
    Am J Emerg Med; 2007 Feb; 25(2):239-40. PubMed ID: 17276835
    [No Abstract]   [Full Text] [Related]  

  • 48. Desmopressin associated symptomatic hyponatremic hypervolemia in children. Are there predictive factors?
    Thumfart J; Roehr CC; Kapelari K; Querfeld U; Eggert P; Müller D
    J Urol; 2005 Jul; 174(1):294-8; discussion 298. PubMed ID: 15947670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Why does a child with enuresis have a seizure?].
    Kajantie E; Kanninen P
    Duodecim; 2000; 116(3):286-8. PubMed ID: 11764452
    [No Abstract]   [Full Text] [Related]  

  • 50. Nocturnal enuresis.
    Bosson S; Lyth N
    Clin Evid; 2002 Jun; (7):341-8. PubMed ID: 12230658
    [No Abstract]   [Full Text] [Related]  

  • 51. Altered mentation and seizure.
    Kulkarni RG; Brown DF; Nadel ES
    J Emerg Med; 2001 Jul; 21(1):59-62. PubMed ID: 11399390
    [No Abstract]   [Full Text] [Related]  

  • 52. Morbidity and mortality associated with vasopressin replacement therapy in children.
    Rizzo V; Albanese A; Stanhope R
    J Pediatr Endocrinol Metab; 2001; 14(7):861-7. PubMed ID: 11515726
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Use of adiuretin SD for various forms of children's enuresis treatment in outpatient practice].
    Kazanskaia IV; Grozdova TIu; Otpushchennikova TV
    Urologiia; 2000; (3):50-3. PubMed ID: 11186714
    [No Abstract]   [Full Text] [Related]  

  • 54. [Clinical reasoning and decision making in practice: a 30-year-old man with unexplained coma].
    van den Born BJ; Hart W; Koopmans RP; Levi M
    Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1612-6. PubMed ID: 16078766
    [TBL] [Abstract][Full Text] [Related]  

  • 55. In human patients, vascular water retention during DDAVP-related hyponatremia occurs mainly in the plasma volume and not in the erythrocyte.
    Namias B; Soupart A; Kornreich A; Decaux G
    J Lab Clin Med; 1996 Dec; 128(6):612-7. PubMed ID: 8960645
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacists have a key role in raising awareness around risks of intranasal desmopressin.
    Kwok J; Gue D; Curtis J; Jackson S
    J Am Pharm Assoc (2003); 2014; 54(5):460-2. PubMed ID: 25216872
    [No Abstract]   [Full Text] [Related]  

  • 57. Lack of elevation of urinary albumin excretion among patients with chronic syndromes of inappropriate antidiuresis.
    Vandergheynst F; Decaux G
    Nephrol Dial Transplant; 2008 Jul; 23(7):2399-401. PubMed ID: 18400823
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Desmopressin (dDAVP) incident signals the need for enhanced monitoring protocols.
    Campigotto MJ; Koczmara C; Greenall J; Hyland S
    Dynamics; 2008; 19(3):34-6. PubMed ID: 18773714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyponatremia may be an under-recognized complication after desmopressin to reduce uremic bleeding in kidney biopsy.
    Lim CC; Chawla M; Siow B; Choo JCJ; Lee PH; Foo M; Tan CS
    Nephrology (Carlton); 2019 Jun; 24(6):674. PubMed ID: 31006950
    [No Abstract]   [Full Text] [Related]  

  • 60. Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia.
    Rembratt A; Riis A; Norgaard JP
    Neurourol Urodyn; 2006; 25(2):105-9. PubMed ID: 16304673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.